Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

UPDATE 1-Cheers and hope as doctor gets Nigeria's first COVID-19 vaccine

Published 05/03/2021, 16:12
Updated 05/03/2021, 16:18
© Reuters

(Adds details on infrastructure, security challenges)
By Camillus Eboh
March 5 (Reuters) - A doctor who has spent the past year
treating COVID-19 patients on Friday became the first person in
Nigeria to be vaccinated against the disease, kicking off a
mammoth campaign that aims to inoculate 80 million people this
year.
Vaccinating all of Nigeria's 200 million people and those in
other developing countries is seen as key to stemming the global
spread of the coronavirus.
"I am happy to be the first and I am happy I am not the
last," the doctor, 42-year-old Ngong Cyprian, told Reuters. "I
want everybody to be vaccinated."
Two other male doctors and one female nurse were also
inoculated in white tents draped in green, the colours of the
national flag, while cameras rolled and officials clapped and
cheered.
Nigeria, with 157,671 confirmed cases of COVID-19 and 1,951
deaths, has not been as hard hit by the pandemic as initially
feared, but is aiming to vaccinate 40% of its people this year,
and a further 30% in 2022.
It took delivery of 3.92 million doses of the
Oxford/AstraZeneca vaccine on Tuesday through the COVAX scheme
and expects to receive 84 million doses via COVAX this year.
The scheme for poor and middle-income countries is co-led by
Gavi, the vaccine alliance, and the World Health Organization,
with UNICEF as an implementing partner.

'LIGHT AT THE END OF THE TUNNEL'
Nigeria also expects at least 40 million doses from the
African Union and 100,000 donated doses of India's Covishield
vaccine. President Muhammadu Buhari and other "strategic leaders"
will be vaccinated on Saturday in an effort to increase public
confidence in the shots.
But getting doses to the rest of the vast nation, with its
pot-holed roads and lawless areas, presents an enormous
challenge. Not all states have functioning airports, and rail
networks are limited. Nigeria's 36 states, including Lagos, the commercial capital
and epicentre of the pandemic in the country, will receive shots
in coming weeks. Seroprevalence studies suggest 23% of Lagos
state inhabitants may have had COVID-19 in October. Faisal Shuaib, executive director of the National Primary
Health Care Development Agency, said sending vaccines to states
would depend on their preparedness, including worker training,
cold chain storage maintenance, security in transit and at
vaccination sites, and a range of other factors.
Large portions of the north face daunting security issues,
including Islamist militants in the northeast and increasingly
bold armed bandits in the northwest who have kidnapped hundreds
of schoolchildren in recent months.
Frontline healthcare workers and employees in key sectors,
including oil and gas, will be among those getting the first
shots, followed by adults with pre-existing conditions. All
those over 18, excluding pregnant women, can then be vaccinated.
"Vaccines provide light at the end of the tunnel, but we
must get to the end of the tunnel," said Chikwe Ihekweazu,
Director General of Nigeria Centre for Disease Control.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.